KASSEL, Germany, June 10, 2013 /PRNewswire/ -- Biozoom (OTC QB: BIZM)
Consistent use of the Biozoom (BIZM) scanner has been shown to help young people make better lifestyle choices, leading to long-term health improvement. Results of a study by Charite University Hospital Berlin found that some adolescents—an audience that often resists calls for healthier living by parents and teachers—made healthier choices on their own after the Biozoom scanner enabled them to see the benefits of those choices. At the end of the study, 83% of participants had higher levels of antioxidants than before, and 20% of the students who smoked had quit smoking. For details regarding this study, see Part 6 Exhibit 99.1 in Biozoom's Current Report on Form 8-K filed on May 31, 2013.
Charite analyzed 50 students of a vocational school in Kassel, Germany with the Biozoom scanner for a period of 2 months. Over the first month, the adolescents were asked not to change their lifestyle or stress conditions. They were measured without being informed of the results. In the second month, they were instructed to make conscious choices to eat healthy foods and reduce stress as far as possible. During this month, they were shown the results of their Biozoom scans. "The young people were initially skeptical of the idea that the ability to measure their antioxidant levels would have any significant effect. But the Biozoom scans allowed them to communicate with their bodies in a new way, and the effect was remarkable," said Dr. Jurgen Lademann, who led the study. Not only did antioxidant levels increase, but all of the students also reported an eagerness to improve their values by desisting from alcohol consumption and smoking. Six months later, the students were scanned again—without advance notice—to determine if their changes were long term.
"In nearly every case, the students reported that they had neglected to follow the healthy lifestyle advice they had received from parents and teachers, but seeing the results of their biofeedback scans changed their minds," Dr. Lademann said.
Antioxidants are widely considered to be important in maintaining health and wellness, but until now there has been no practical way for consumers to measure their antioxidant levels. While laboratory-based tests exist, they are expensive, time consuming and not practical for use outside of a clinic. The Biozoom scanner changes that: "Before we used the Biozoom scanner in the field, we conducted studies comparing its results with the Raman spectrometer we have used for 10 years," said Dr. Jurgen Lademann. "The correlation between the two is very high." Biozoom enabled researchers to scan the students conveniently, at school.
"This study gives us a glimpse of the profound effect the Biozoom scanner can have on behavior. It is one thing to know intellectually that adopting a healthy lifestyle is beneficial," said Biozoom's CEO Hardy Hoheisel, himself a triathlete and fitness enthusiast. "It is quite another to be able to see improvements day by day and week by week. We believe that the Biozoom scanner will have a tremendous impact. It is so simple that anyone can use it anywhere to actively manage their wellness."
Biozoom is an innovative technology development company, specializing in the commercialization of our advances in mobile spectroscopy. Our intellectual property portfolio and ongoing research are positioned to apply Biozoom's technology breakthroughs to a wide range of markets. Our first consumer product, the Biozoom scanner, gives people the feedback they need to manage their health, wellness and fitness on demand. Tested in leading health institutions, our scanner is the first of its kind—a handheld, transdermal device for measuring biomarkers, including antioxidant levels, at the click of a button. Scan results— and customized wellness coaching based on those biomarkers— are sent instantly to a smartphone or online account. The scanner will enable leaders in the health and wellness industry to create new levels of customer loyalty and revenues as a result. For more information, visit www.biozoom.net.
About Charite Berlin
The Charite is one of the largest university hospitals in Europe. Here, 3800 doctors and scientists heal, do research and teach at the top international level. More than half of the German Nobel Prize winners in medicine and physiology come from the Charite, among them Emil von Behring, Robert Koch and Paul Ehrlich. The Charite also has an international reputation for excellence in training. It extends over four campuses with more than 100 clinics and institutes bundled under 17 Charite Centers. With 13,000 employees, the Charite generates about 1.2 billion euros in sales per year and is one of the largest employers in Berlin. In 2010, the Charite could look back and joyously celebrated its 300-year anniversary.
The foregoing description of the Charite University Hospital Berlin study is qualified in its entirety by the full text of Exhibit 99.1 to Biozoom's Current Report on Form 8-K filed on May 31, 2013, which is incorporated herein. This press release contains "forward-looking statements". Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, and specifically references to future potential purchase orders and re-orders from consumers and distributors. The reader can identify these forward-looking statements by forward-looking words such as "may," "will," "expect," "potential," "anticipate," "forecast," "believe," "estimate," "project," "plan," "continue" or similar words. The reader should read statements that contain these words carefully because they discuss future expectations, contain projections of future results of operations or of financial condition, or state other forward-looking information. Forward-looking statements include, but are not limited to, statements regarding potential products, customers, revenues, expansion efforts, and future plans and objectives of Biozoom, Inc. ("Biozoom"). The risk factors listed in our disclosure documents and the cautionary language therein provide examples of risks, uncertainties and events that may cause actual results to differ materially from the expectations and projections described by Biozoom in its forward-looking statements. Actual results relating to, among other things, product launch, sales, customer acceptance and market share could differ materially from those currently anticipated in such statements. Factors affecting forward-looking statements include: consumer preferences, competition from more established brands, ability to develop market share; changes in the operating costs; changes in economic conditions, foreign exchange and other financial markets; changes of the interest rates on borrowings; changes in the investments levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Biozoom operates; technological, mechanical and operational difficulties encountered in connection with Biozoom's development activities; and labor relation matters and costs. The reader should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Biozoom from time to time with the Securities and Exchange Commission and other regulatory authorities.